Latest filing published 27 Sept 2012 for Aevi Genomic Medicine, LLC, €2,965.
Insider track record
No signal scores available.
Stephen Bellomo: trading record in brief
This profile gathers the share dealings of Stephen Bellomo in Aevi Genomic Medicine, LLC. In total, 3 filings cover trades dated from 10 September 2012 to 20 September 2012.
No open-market purchase appears, only 1 sale worth €2,965. The rest of the record consists of 1 share grant and 1 option exercise.
On 27 September 2012 came the latest disclosure, an open-market sale for €2,965 in Aevi Genomic Medicine, LLC. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephen Bellomo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 350 shares@ US$10.99Common StockSEC:0001144204-12-053224:0
- 891 shares@ US$7.35Common StockSEC:0001144204-12-050890:0
- 541 shares@ US$12.10Common StockSEC:0001144204-12-050890:1
3 of 3 declarations